Literature DB >> 14726371

Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication.

Loretta Gammaitoni1, Katja C Weisel, Monica Gunetti, Kai-Da Wu, Stefania Bruno, Silvana Pinelli, Antonio Bonati, Massimo Aglietta, Malcolm A S Moore, Wanda Piacibello.   

Abstract

Telomerase activity, telomere length, stem/progenitor cell production, and function of CD34+ cells from cord blood (CB), bone marrow, and mobilized peripheral blood were evaluated in long-term cultures. CB cells were cultured either on OP-9 stromal cells transduced with an adenovector expressing thrombopoietin (TPO) or stimulated by a cytokine cocktail in the absence of stroma, with, in one method, CD34+ cells reisolated at monthly intervals for passage. Continuous expansion of stem cells as measured by in vitro cobblestone area and secondary colony-forming assays was noted for 18 to 20 weeks and by severe combined immunodeficiency (SCID)-repopulating cells (SRCs), capable of repopulating and serially passage in nonobese diabetic/SCID mice, for 16 weeks. Despite this extensive proliferation, telomere length initially increased and only at late stages of culture was evidence of telomere shortening noted. This telomere stabilization correlated with maintenance of high levels of telomerase activity in the CD34+ cell population for prolonged periods of culture. Cytokine-stimulated cultures of adult CD34+ cells showed CD34+ and SRC expansion (6-fold) for only 3 to 4 weeks with telomere shortening and low levels of telomerase. There is clearly a clinical value for a system that provides extensive stem cell expansion without concomitant telomere erosion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726371     DOI: 10.1182/blood-2003-09-3079

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Cord blood stem cells for hematopoietic transplantation.

Authors:  Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

3.  The application of umbilical cord blood cells in the treatment of diabetes mellitus.

Authors:  Tomas Koblas; S Mitchell Harman; Frantisek Saudek
Journal:  Rev Diabet Stud       Date:  2006-02-10

4.  Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.

Authors:  M Howe; J Zhao; Y Bodenburg; C P McGuckin; N Forraz; R G Tilton; R J Urban; L Denner
Journal:  Cell Prolif       Date:  2009-03-25       Impact factor: 6.831

5.  Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings.

Authors:  Asm Iskander; Robert A Knight; Zheng Gang Zhang; James R Ewing; Adarsh Shankar; Nadimpalli Ravi S Varma; Hassan Bagher-Ebadian; Meser M Ali; Ali S Arbab; Branislava Janic
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

6.  Usefulness of umbilical cord blood cells in era of hematopoiesis research.

Authors:  Seong-Kyu Park; Jong-Ho Won
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

7.  Effects of telomerase activity and apoptosis on ex vivo expansion of cord blood CD34(+) cells.

Authors:  J Ge; H Cai; Q Li; Z Du; W S Tan
Journal:  Cell Prolif       Date:  2012-12-15       Impact factor: 6.831

8.  Cord blood endothelial progenitor cells as therapeutic and imaging probes.

Authors:  Branislava Janic; Ali S Arbab
Journal:  Imaging Med       Date:  2012-08-01

9.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.

Authors:  Cheng Cheng Zhang; Megan Kaba; Satoru Iizuka; HoangDinh Huynh; Harvey F Lodish
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

10.  Cell-cell interaction networks regulate blood stem and progenitor cell fate.

Authors:  Daniel C Kirouac; Gerard J Madlambayan; Mei Yu; Edward A Sykes; Caryn Ito; Peter W Zandstra
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.